Why do we need to eradicate pathogens in respiratory tract infections?

This publication has 29 references indexed in Scilit:

• Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence
  Journal of Antimicrobial Chemotherapy, 2002
• Clinical Outcomes of Bacteremic Pneumococcal Pneumonia in the Era of Antibiotic Resistance
  Clinical Infectious Diseases, 2001
• Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy
  Journal of Antimicrobial Chemotherapy, 2001
• Relationship between Capsular Type, Penicillin Susceptibility, and Virulence of Human Streptococcus pneumoniae Isolates in Mice
  Antimicrobial Agents and Chemotherapy, 2000
• Impact of Penicillin Susceptibility on Medical Outcomes for Adult Patients with Bacteremic Pneumococcal Pneumonia
  Clinical Infectious Diseases, 2000
• Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
  American Journal of Public Health, 2000
• Bacteriologic Efficacies of Oral Azithromycin and Oral Cefaclor in Treatment of Acute Otitis Media in Infants and Young Children
  Antimicrobial Agents and Chemotherapy, 2000
• Penicillin Resistance and Other Predictors of Mortality in Pneumococcal Bacteremia in a Population with High Human Immunodeficiency Virus Seroprevalence
  Clinical Infectious Diseases, 1999
• Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome
  The Pediatric Infectious Disease Journal, 1998
• Efficacy and Tolerability of Azithromycin versus Amoxicillin/Clavulanic Acid in Acute Purulent Exacerbation of Chronic Bronchitis
  Journal of Chemotherapy, 1995